Results 231 to 240 of about 291,495 (261)

Overexpression of O‐polysaccharide chain length regulators in Gram‐negative bacteria using the Wzx‐/Wzy‐dependent pathway enhances production of defined modal length O‐polysaccharide polymers for use as haptens in glycoconjugate vaccines

Journal of Applied Microbiology, 2018
Myron M Levine, J E Galen
exaly  

Rapid and complete adsorption of unconjugated protein from protein-polysaccharide conjugate vaccines

Vaccine, 2001
Andrew Lees
exaly  

Epitopic overload at the site of injection may result in suppression of the immune response to combined capsular polysaccharide conjugate vaccines

Vaccine, 1999
Chiayung Chu, Louis Fries, A Fattom
exaly  

Immunogenicity and safety of pneumococcal conjugate polysaccharide and free polysaccharide vaccines alone or combined in HIV-infected adults in Brazil

Vaccine, 2013
Marta Heloisa Lopes, Yeh-Li Ho
exaly  

Polysaccharide vaccine for staphylococcal infections

2004
PIER GERALD B, MAIRA-LITRAN TOMAS
openaire   +7 more sources

Polysaccharide Vaccines

2009
openaire   +1 more source

Quantification of polysaccharide in Haemophilus influenzae type b conjugate and polysaccharide vaccines by high-performance anion-exchange chromatography with pulsed amperometric detection

Vaccine, 1994
R Andrew Byrd, Chao-Ming Tsai, Xin-Xing Gu   +2 more
exaly  

Polysaccharide Vaccines

1993
openaire   +1 more source

Polysaccharide Vaccine

2010
openaire   +1 more source

Comparison of Neisseria meningitidis serogroup W135 polysaccharide–tetanus toxoid conjugate vaccines made by periodate activation of O-acetylated, non-O-acetylated and chemically de-O-acetylated polysaccharide

Vaccine, 2007
Maneesh Paul-Satyaseela, Willie Vann, Carl E Frasch   +2 more
exaly